| Patent | Date |
|---|
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
App 20210095013 - Duerr; Harald ; et al. | 2021-04-01 |
Combination Therapy Of Antibodies Against Human Csf-1r And Antibodies Against Human Pd-l1
App 20200392234 - HERTING; Frank ; et al. | 2020-12-17 |
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
Grant 10,683,345 - Duerr , et al. | 2020-06-16 |
Antibody Fab And Fc Variants
App 20190106502 - Bruenker; Peter ; et al. | 2019-04-11 |
Antibody Fc And Fab Variants
App 20190092872 - Bruenker; Peter ; et al. | 2019-03-28 |
Combination Therapy Of Antibodies Against Human Csf-1r And Antibodies Against Human Pd-l1
App 20180346581 - HERTING; Frank ; et al. | 2018-12-06 |
Combination Therapy Of Antibody Binding To Angiopoietin 2 With Antibody Binding To Programmed Death Ligand 1
App 20180155431 - Herting; Frank ; et al. | 2018-06-07 |
Bispecific Anti-vegf/anti-ang-2 Antibodies And Their Use In The Treatment Of Ocular Vascular Diseases
App 20170260265 - Duerr; Harald ; et al. | 2017-09-14 |
Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases
Grant 9,695,233 - Duerr , et al. July 4, 2 | 2017-07-04 |
Combination Therapy Of Antibodies Against Human Csf-1r And Antibodies Against Human Pd-l1
App 20170051065 - HERTING; Frank ; et al. | 2017-02-23 |
Combination therapy of an anti-CD20 antibody with a Bcl-2 inhibitor and a MDM2 inhibitor
App 20160347852 - Klein; Christian ; et al. | 2016-12-01 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20160166688 - HERTING; FRANK ; et al. | 2016-06-16 |
Combination Therapy Of An Afucosylated Cd20 Antibody With An Anti-vegf
App 20160017050 - Herting; Frank ; et al. | 2016-01-21 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20160000911 - DUMONTET; CHARLES ; et al. | 2016-01-07 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20150274834 - Dreyling; Martin ; et al. | 2015-10-01 |
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20150265703 - Herting; Frank ; et al. | 2015-09-24 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20150093376 - HERTING; FRANK ; et al. | 2015-04-02 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20150079073 - DREYLING; MARTIN ; et al. | 2015-03-19 |
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20150071911 - HERTING; FRANK ; et al. | 2015-03-12 |
Combination therapy of antibodies against human CSF-1R and antibodies agains human PD-L1
App 20150073129 - Herting; Frank ; et al. | 2015-03-12 |
Combination Therapy Of An Afucosylated Cd20 Antibody With An Anti-vegf Antibody
App 20140322200 - HERTING; FRANK ; et al. | 2014-10-30 |
Combination Therapy Of An Afucosylated Cd20 Antibody With A Mdm2 Inhibitor
App 20140140988 - ELDERING; ERIC ; et al. | 2014-05-22 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20140065134 - DUMONTET; CHARLES ; et al. | 2014-03-06 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20140044705 - HERTING; FRANK ; et al. | 2014-02-13 |
Bispecific Anti-VEGF/Anti-ANG-2 Antibodies and their use in the Treatment of Ocular Vascular Diseases
App 20140017244 - Duerr; Harald ; et al. | 2014-01-16 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20140010804 - DREYLING; MARTIN ; et al. | 2014-01-09 |
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A mTOR INHIBITOR
App 20130280243 - HERTING; FRANK ; et al. | 2013-10-24 |
Combination Therapy Of An Afucosylated Cd20 Antibody With An Anti-vegf Antibody
App 20130183290 - Herting; Frank ; et al. | 2013-07-18 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20120315268 - Herting; Frank ; et al. | 2012-12-13 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20120301459 - Dumontet; Charles ; et al. | 2012-11-29 |
Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone
App 20120263713 - Dreyling; Martin ; et al. | 2012-10-18 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20110177067 - Dumontet; Charles ; et al. | 2011-07-21 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Fludarabine And/or Mitoxantrone
App 20110165152 - Dreyling; Martin ; et al. | 2011-07-07 |
Combination Therapy Of An Afucosylated Cd20 Antibody With Bendamustine
App 20110165151 - HERTING; FRANK ; et al. | 2011-07-07 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20100310581 - Dumontet; Charles ; et al. | 2010-12-09 |
Treatment of neurodegenerative disorders
App 20100267632 - Haselbeck; Anton ; et al. | 2010-10-21 |
Hydroxamates, their manufacture and use as pharmaceutical agents
Grant 7,638,553 - Fertig , et al. December 29, 2 | 2009-12-29 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20090246197 - DUMONTET; CHARLES ; et al. | 2009-10-01 |
Mono-acylated o-phenylendiamines derivatives
Grant 7,501,451 - Fertig , et al. March 10, 2 | 2009-03-10 |
Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors
Grant 7,423,060 - Fertig , et al. September 9, 2 | 2008-09-09 |
Thiophene derivatives, their manufacture and use as pharmaceutical agents
Grant 7,396,944 - Fertig , et al. July 8, 2 | 2008-07-08 |
Hydroxamates, Their Manufacture And Use As Pharmaceutical Agents
App 20080139640 - Fertig; Georg ; et al. | 2008-06-12 |
Thiophene Hydroxamic Acid Derivatives and Their Use as Hdac Inhibitors
App 20080070976 - Fertig; Georg ; et al. | 2008-03-20 |
Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents
App 20070232602 - Fertig; Georg ; et al. | 2007-10-04 |
N-monoacylated o-phenylenediamines
Grant 7,208,491 - Fertig , et al. April 24, 2 | 2007-04-24 |
Treatment of neurodegenerative disorders
App 20070072795 - Haselbeck; Anton ; et al. | 2007-03-29 |
Oxime derivatives and their use as pharmaceutically active agents
Grant 7,173,060 - Fertig , et al. February 6, 2 | 2007-02-06 |
Thiophene hydroxamic acid derivatives
Grant 7,098,241 - Grossmann , et al. August 29, 2 | 2006-08-29 |
Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
Grant 7,098,247 - Fertig , et al. August 29, 2 | 2006-08-29 |
Mono-acylated o-phenylendiamines derivatives
Grant 7,071,219 - Fertig , et al. July 4, 2 | 2006-07-04 |
Mono-acylated o-phenylendiamines derivatives
App 20060089403 - Fertig; Georg ; et al. | 2006-04-27 |
Oxime derivatives and their use as pharmaceutically active agents
App 20040214880 - Fertig, Georg ; et al. | 2004-10-28 |
Mono-acylated o-phenylendiamines derivatives
App 20040162317 - Fertig, Georg ; et al. | 2004-08-19 |
N-monoacylated o-phenylenediamines
App 20040157841 - Fertig, Georg ; et al. | 2004-08-12 |
Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives
App 20040138270 - Fertig, Georg ; et al. | 2004-07-15 |
Thiophene hydroxamic acid derivatives
App 20040122079 - Grossmann, Adelbert ; et al. | 2004-06-24 |
| 